Back to 
Capital Wealth Planning, LLC
Capital Wealth Planning, LLC
AZN2 quarters
Position history for Capital Wealth Planning, LLC's holdings in ASTRAZENECA PLC
Yes. Capital Wealth Planning holds 215,993 shares of AZN (AstraZeneca), worth $41M, as of its Q2 2026 13F filing. It increased the position by 82,396 shares (+61.7%) from Q1 2026. Capital Wealth Planning has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.2% of Capital Wealth Planning's reported 13F portfolio.
Current Value
$41M
Current Shares
215,993
Total Value Change
+$14.6M
Total Shares Change
+82,396
Quarter-by-Quarter History
Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK